European biotech is a hot topic among investors. They have supported as many start-ups as in the US but have seen far from equivalent returns. So what's going on? Science|Business talks to biotechnology consultant John Hodgson.
A new high-speed electronic network is set to transform collaboration between 45 million researchers and students in Europe and China when it goes live later this year.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.